Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-Centre Study of the Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

NCT03248960 is registered in ClinicalTrials.gov with Ellume Pty Ltd as lead sponsor.

NCT NCT03248960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-Centre Study of the Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.
Lead sponsor
Ellume Pty Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 27, 2017
Completion date
December 23, 2017
Enrollment
381 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

influenza